Sunday, November 23, 2008

Health

USN Current Issue

Where TB's Danger Lies

By Bernadine Healy M.D.
Posted 6/10/07
Page 2 of 2

Dormant disease. There's another way the United States is a sieve for TB: We import "latent" infection, a dormant form of the disease (which shows up with a simple skin test) in which the immune system keeps the microbe in check. Our immigration health screens don't target this or require treatment if it's discovered as they do for active TB, since it's not contagious. But 10 percent of latent disease becomes active and contagious, something that can be prevented by drug therapy. Randall Reves, medical director of the Denver Metro Tuberculosis Control Program, stresses that targeted testing of high-risk populations for latent TB, with mandatory treatment, is critical to wiping out the disease. The CDC agrees. So does the Institute of Medicine in its report "Ending Neglect." Ending neglect is a tall task calling for this and more: Better and faster diagnostic tests and treatment. Drugs to overcome resistance. An effective TB vaccine. Intense global efforts to stamp out TB in hot spots. And a major investment in America's own public-health system.

If a burst of public anger at one man with TB who boarded a plane against medical advice brings focus to these issues, that's a good thing. We may come to realize, as Reves suggests, that the public-health system's inability to better control the transmission of high-risk TB failed Speaker a lot more than he failed anyone else.

advertisement

advertisement

Symptom Search

American Hospital Association Symptom Finder

Discover possible causes of your symptoms.

NEWSLETTER

Sign up today for the latest headlines from U.S. News and World Report delivered to you free.

RSS FEEDS

Personalize your U.S. News with our feeds of blogs and breaking news headlines.

USNews MOBILE

U.S. News daily briefings are also available on your mobile device.

Use of this Web site constitutes acceptance of our Terms and Conditions of Use and Privacy Policy.